Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)

NCT06101342 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

181

Enrollment

INDUSTRY

Sponsor class

Conditions

Pre-Exposure Prophylaxis of HIV Infection

Interventions

DRUG: Lenacapavir Injection
DRUG: Lenacapavir Tablet
DRUG: Emtricitabine/tenofovir disoproxil fumarate (F/TDF)

Sponsor

Gilead Sciences

Collaborators

[object Object]
[object Object]
[object Object]